NEW YORK (GenomeWeb News) – Startup drug developer Constellation Pharmaceuticals will use BioTrove’s screening and analysis system to develop new therapeutics using an epigenetics-focused approach, BioTrove said today.
 
Constellation will use BioTrove’s RapidFire mass spectrometry system in its screening efforts aimed at developing drugs that can manipulate histone proteins to alter gene expression.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.